Table 1 Patients’ characteristics
All | Leiomyosarcoma | Carcinosarcoma | |
|---|---|---|---|
N = 1635 | n = 566 | n = 1069 | |
Age ≥ 60 years | 1028 (62.9) | 175 (30.9) | 1934 (79.8) |
Race | |||
White | 1162 (71.1) | 397 (70.1) | 765 (71.6) |
Black | 324 (19.8) | 111 (19.4) | 214 (20.0) |
Other a | 145 (8.9) | 56 (9.9) | 89 (8.3) |
Unknown | 4 (0.2) | 3 (0.5) | 1 (0.1) |
Year of diagnosis after 2009 | 1635 (100) | 566 (100.0) | 1069 (100.0) |
AJCC Stage | |||
Stage I | 1070 (65.4) | 443 (78.3) | 627 (58.7) |
Stage II | 153 (9.4) | 66 (11.7) | 87 (8.1) |
Stage III | 412 (25.2) | 57 (10.0) | 355 (33.2) |
Grade | |||
Grade 1 | 34 (2.1) | 21 (3.7) | 13 (1.2) |
Grade 2 | 81 (5.0) | 53 (9.3) | 28 (2.6) |
Grade 3 | 539 (33.0) | 91 (16.1) | 448 (41.9) |
Undifferentiated/anaplastic | 380 (23.2) | 146 (25.8) | 234 (21.9) |
Unknown | 601 (36.7) | 255 (45.1) | 346 (32.4) |
Tumor size | |||
≤ 50 mm | 461 (28.2) | 87 (15.4) | 374 (35.0) |
> 50 mm | 974 (59.6) | 424 (74.9) | 550 (51.5) |
Unknown | 200 (12.2) | 55 (9.7) | 145 (13.5) |
Lymphadenectomy | |||
No | 583 (35.7) | 374 (66.1) | 209 (19.6) |
Yes | 1025 (62.7) | 185 (32.7) | 840 (78.6) |
Unknown | 27 (1.7) | 7 (1.2) | 20 (1.8) |
Adjuvant radiation | |||
No treatment | 1117 (68.3) | 476 (84.1) | 641 (60.0) |
EBRT alone | 242 (14.8) | 64 (11.3) | 178 (16.7) |
Brachytherapy alone | 159 (9.7) | 11 (1.9) | 148 (13.8) |
Combination radiotherapy b | 95 (5.8) | 13 (2.3) | 82 (7.7) |
Others | 22 (1.4) | 2 (0.4) | 20 (1.8) |